fluoxetine and tiagabine

fluoxetine has been researched along with tiagabine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Connor, KM; Davidson, JR; Foa, EB; Hertzberg, MA; Payne, VM; Rothbaum, BO; Weisler, RH1

Reviews

1 review(s) available for fluoxetine and tiagabine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for fluoxetine and tiagabine

ArticleYear
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder.
    International clinical psychopharmacology, 2005, Volume: 20, Issue:1

    Topics: Adaptation, Psychological; Adult; Cognitive Behavioral Therapy; Female; Fluoxetine; GABA Agonists; Humans; Male; Middle Aged; Nipecotic Acids; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Tiagabine; Treatment Outcome

2005

Other Studies

2 other study(ies) available for fluoxetine and tiagabine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010